🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will provide data on the addition of narrow band ultra violet B ...
Status
Completed
Location
Winnipeg Clinic
Start Date
2008-04
Trial ID
NCT00640393
Treatments Being Tested
The purpose of this study is to determine whether there is an increase in t...
Status
Unknown
Location
Istanbul Medeniyet University
Start Date
2023-05-01
Trial ID
NCT06000189
Treatments Being Tested
The purpose of this study is to look at the efficacy of afamelanotide, when...
Status
Completed
Location
Henry Ford Medical Center
Start Date
2011-06
Trial ID
NCT01430195
Treatments Being Tested
The purpose of this study is to determine whether afamelanotide and narrow ...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01382589
Treatments Being Tested
This study is designed to evaluate the efficacy of AMG 714 for the treatmen...
Status
Completed
Location
University of California, Irvine: Department of Dermatology
Start Date
2020-12-11
Trial ID
NCT04338581
Treatments Being Tested
This is a proof of concept, investigator blinded study to evaluate the effi...
Status
Unknown
Location
Redwood Family Dermatology
Start Date
2015-05
Trial ID
NCT02447068
Treatments Being Tested
This is a single-center, open-label, pilot study. A total of 30 subjects (1...
Status
Completed
Location
UCSF Psoriasis and Skin Treatment Center
Start Date
2008-10
Trial ID
NCT00800982
Treatments Being Tested
Vitiligo is a common chronic autoimmune disease that causes the body's immu...
Status
Active Not Recruiting
Location
Advanced Research Associates - Glendale /ID# 259915
Start Date
2023-12-19
Trial ID
NCT06118411
Treatments Being Tested
The purpose of this study was to determine whether early intervention with ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-03-27
Trial ID
NCT03020199
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Ruxolit...
Status
Completed
Location
First Oc Dermatology
Start Date
2022-05-05
Trial ID
NCT05247489
Treatments Being Tested